COVID-19 has disrupted the traditional clinical trial landscape by stopping or interrupting 70-80% of all trials. In this new environment, pharmaceutical and life science companies need to uncover how to best create and implement virtual clinical trials. |
|
As a result of the pandemic, life science companies need to shift and adapt their approach to clinical trials. In our webinar, we’ll share how to: